Analysis of phage therapy failure in a patient with aPseudomonas aeruginosaprosthetic vascular graft infection

Abstract

AbstractClinical case of a patient with aPseudomonas aeruginosamultidrug-resistant prosthetic vascular graft infection which was treated with a cocktail of phages (PT07, 14/01 and PNM) in combination with ceftazidime-avibactam (CAZ/AVI). After the application of the phage treatment and in absence of antimicrobial therapy, a newP. aeruginosabloodstream infection (BSI) with a septic residual limb metastasis occurred, now involving a wild-type strain being susceptible to ß-lactams and quinolones. Clinical strains were analyzed by microbiology and whole genome sequencing techniques. In relation with phage administration, the clinical isolates ofP. aeruginosabefore phage therapy (HE2011471) and post phage therapy (HE2105886) showed a clonal relationship but with important genomic changes which could be involved in the resistance to this therapy. Finally, phenotypic studies showed a decreased in Minimum Inhibitory Concentration (MIC) to ß-lactams and quinolones as well as an increase of the biofilm production and phage resistant mutants in the clinical isolate ofP. aeruginosapost phage therapy.ImportancePhage therapy is a promising new treatment against infections produced by multi-drug resistant pathogens. For that, it would be necessary to know more about the clinical response and host-phage interactions by massive sequencing techniques to improve phage therapy application. In this work, we analyzed the clinical, microbiological and molecular features of theP. aeruginosaisolates in prosthetic vascular graft infection after the phages administration failure against this infection. This knowledge could allow to develop strategies of improvement of the use of phage therapy as treatment of multiple clinical infections.